Trial Profile
The use of amisulpride in schizophrenic acute phase patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2009
Price :
$35
*
At a glance
- Drugs Amisulpride (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Acronyms ASAP
- Sponsors Sanofi
- 19 Nov 2007 Status changed from in progress to completed.
- 21 Mar 2007 New trial record.